Metzger Michael A 的 Form 4 申報
Cti Biopharma Corp（CTIC），2022/7/7 申報
- 申報編號
- 0000891293-22-000035
- 申報時間
- 2022/7/7
- 交易日
- 2022/7/5
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $55.6 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Metzger Michael ACIK 0001507220 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/7/5 | common stock | M行使選擇權取得 | +91,500 | $0.84 | +$76,860 | 111,621 | 直接 | |
| 2022/7/5 | common stock | S賣出處分 | −8,700 | $5.98F2 | −$52,026 | 102,921 | 直接 | |
| 2022/7/5 | common stock | S賣出處分 | −51,963 | $6.05F3 | −$314,376.15 | 50,958 | 直接 | |
| 2022/7/5 | common stock | S賣出處分 | −27,506 | $6.14F4 | −$168,886.84 | 23,452 | 直接 | |
| 2022/7/5 | common stock | S賣出處分 | −3,331 | $6.23F5 | −$20,752.13 | 20,121 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/7/5 | Common Stock | M行使選擇權處分 | −91,500 | $0.00 | $0 | 28,500 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.95 to $ 5.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 6.00 to $ 6.10. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 6.11 to $ 6.20. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 6.21 to $ 6.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。